Published in Eur J Clin Invest on December 01, 1999
Pregnancy and preeclampsia affect monocyte subsets in humans and rats. PLoS One (2012) 0.89
Adhesion molecules in different treatments of acute myocardial infarction. Crit Care (2001) 0.79
Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med (1990) 3.93
Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J Biol Chem (1992) 3.64
AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011. Pharmacopsychiatry (2011) 2.91
Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins. J Exp Med (1989) 2.69
Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties. J Exp Med (1989) 2.52
Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Neurosci Lett (1995) 2.19
Effects of inhaled nitric oxide on right ventricular function in severe acute respiratory distress syndrome. Intensive Care Med (1995) 2.07
High survival rate in 122 ARDS patients managed according to a clinical algorithm including extracorporeal membrane oxygenation. Intensive Care Med (1997) 1.89
Hypoxia modulates the barrier and coagulant function of cultured bovine endothelium. Increased monolayer permeability and induction of procoagulant properties. J Clin Invest (1990) 1.84
[Diencephalic pilocytic astrocytoma with clinical onset in infancy. Biological behavior and pathomorphological findings in 11 children]. Zentralbl Allg Pathol (1985) 1.76
Breast milk from mothers of very low birthweight infants: variability in fat and protein content. Acta Paediatr (2001) 1.74
Tumor necrosis factor/cachectin-induced intravascular fibrin formation in meth A fibrosarcomas. J Exp Med (1988) 1.71
Corticosteroids for treating severe sepsis and septic shock. Cochrane Database Syst Rev (2004) 1.65
The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry. Pharmacopsychiatry (2004) 1.64
Brain iron pathways and their relevance to Parkinson's disease. J Neurochem (2001) 1.55
Aerosolized prostacyclin versus inhaled nitric oxide in children with severe acute respiratory distress syndrome. Anesthesiology (1995) 1.52
Probiotics for prevention of necrotising enterocolitis: an updated meta-analysis. Klin Padiatr (2010) 1.50
A clinical pilot study of fresh frozen plasma versus human albumin in paediatric craniofacial repair. J Int Med Res (2008) 1.48
[ILCOR's new resuscitation guidelines in preterm and term infants: critical discussion and suggestions for implementation]. Klin Padiatr (2007) 1.45
Pre-hospital discharge testing after implantable cardioverter defibrillator implantation: a measure of safety or out of date? A retrospective analysis of 975 patients. Europace (2011) 1.43
Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson's disease. Prog Neurobiol (2005) 1.37
Clinical implications of antibiotic-induced endotoxin release in septic shock. Intensive Care Med (2002) 1.34
Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes. J Neurochem (2001) 1.33
Patent ductus arteriosus in very low birthweight infants: complications of pharmacological and surgical treatment. J Perinat Med (2001) 1.29
Inhaled nitric oxide: its effects on pulmonary circulation and airway smooth muscle cells. Eur Heart J (1993) 1.28
High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study. J Neural Transm (Vienna) (2004) 1.26
Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder. Neurotox Res (2006) 1.26
Neuropathic gastric dilatation in psittaciformes. Avian Dis (1987) 1.23
Intraoperative thoracic epidural anaesthesia attenuates stress-induced immunosuppression in patients undergoing major abdominal surgery. Br J Anaesth (2008) 1.20
Early detection of increased tumour necrosis factor alpha (TNFalpha) and soluble TNF receptor protein plasma levels after trauma reveals associations with the clinical course. Acta Anaesthesiol Scand (2001) 1.16
Whole body hyperthermia: a secure procedure for patients with various malignancies? Intensive Care Med (1999) 1.15
Nitric oxide inhibits tissue factor synthesis, expression and activity in human monocytes by prior formation of peroxynitrite. Intensive Care Med (1998) 1.10
Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour. Mol Pathol (2001) 1.09
A polypeptide factor produced by fibrosarcoma cells that induces endothelial tissue factor and enhances the procoagulant response to tumor necrosis factor/cachectin. J Biol Chem (1990) 1.09
Early cessation of breast milk feeding in very low birthweight infants. Early Hum Dev (2001) 1.08
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level. Brain Res (1996) 1.06
Allelic variation of serotonin transporter expression is associated with depression in Parkinson's disease. Mol Psychiatry (2001) 1.05
The N-methyl-D-aspartate antagonist memantine retards progression of Huntington's disease. J Neural Transm Suppl (2004) 1.04
Renal impairment in patients with long-standing cyanotic congenital heart disease. Acta Paediatr (1998) 1.02
Microglia activation is related to substantia nigra echogenicity. J Neural Transm (Vienna) (2010) 1.01
Lack of hypoxic stimulation of VEGF secretion from neutrophils and platelets. Am J Physiol Heart Circ Physiol (2000) 1.01
Enhancement of central nervous system pathology in early simian immunodeficiency virus infection by dopaminergic drugs. Acta Neuropathol (2001) 1.00
Neurodevelopment at 1 year of age in infants with congenital heart disease. Heart (2003) 0.98
Pretreatment with nimodipine prevents MPTP-induced neurotoxicity at the nigral, but not at the striatal level in mice. Neuroreport (1995) 0.95
Efficacy of inhaled nitric oxide in patients with severe ARDS. Chest (1995) 0.94
[Macrotetrolides]. Fortschr Chem Org Naturst (1968) 0.93
Histologic changes and inclusion bodies in chickens inoculated with an ornithiosis agent. Avian Dis (1968) 0.93
BCR-ABL and v-SRC tyrosine kinase oncoproteins support normal erythroid development in erythropoietin receptor-deficient progenitor cells. Proc Natl Acad Sci U S A (1999) 0.93
Time course of organ failure in patients with septic shock treated with hydrocortisone: results of the Corticus study. Intensive Care Med (2011) 0.93
Structural characteristics of human substantia nigra neuromelanin and synthetic dopamine melanins. J Neurochem (2000) 0.92
Extracorporeal membrane oxygenation for transport of hypoxaemic patients with severe ARDS. Br J Anaesth (1997) 0.92
Active site-blocked factor IXa prevents intravascular thrombus formation in the coronary vasculature without inhibiting extravascular coagulation in a canine thrombosis model. J Clin Invest (1991) 0.92
Impaired iron homeostasis in Parkinson's disease. J Neural Transm Suppl (2000) 0.91
[Mycobacteria in parrots and parakeets (Psittaciformes)]. Dtsch Tierarztl Wochenschr (1988) 0.91
Autocrine tumor cell growth-inhibiting activities from human malignant melanoma. Cancer Res (1989) 0.91
[Avian mycobacteriosis caused by strains not yet identifiable]. Zentralbl Veterinarmed B (1991) 0.91
Depression in Parkinson's disease: biogenic amines in CSF of "de novo" patients. J Neural Transm (Vienna) (1996) 0.91
In vitro studies of ferritin iron release and neurotoxicity. J Neurochem (1998) 0.90
Down-regulation of L-selectin surface expression by various leukocyte isolation procedures. Scand J Immunol (1994) 0.90
Influence of neuromelanin on oxidative pathways within the human substantia nigra. Neurotoxicol Teratol (2002) 0.90
[Dabigatran therapy--perioperative management and interpretation of coagulation tests]. Hamostaseologie (2012) 0.90
Early expression of glutamate transporter proteins in ramified microglia after controlled cortical impact injury in the rat. Glia (2001) 0.90
Advanced glycation end products in neurodegeneration: more than early markers of oxidative stress? Ann Neurol (1998) 0.89
Relationships between various behavioural abnormalities and nigrostriatal dopamine depletion in the unilateral 6-OHDA-lesioned rat. Behav Brain Res (2003) 0.89
Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline. J Neural Transm (Vienna) (2001) 0.89
Guidelines for sclerotherapy of varicose veins (ICD 10: I83.0, I83.1, I83.2, and I83.9). Dermatol Surg (2004) 0.88
Chronic alcohol consumption and cerebral indices of oxidative stress: is there a link? Alcohol Clin Exp Res (2001) 0.88
[New macrotetralides from actinomyces]. Helv Chim Acta (1967) 0.88
Oral isobutyramide reduces transfusion requirements in some patients with homozygous beta-thalassemia. Blood (2000) 0.88
Dopamine receptor agonists in the therapy of Parkinson's disease. J Neural Transm (Vienna) (2003) 0.88
Sirolimus inhibits growth of human hepatoma cells in contrast to tacrolimus which promotes cell growth. Transplant Proc (2002) 0.88
[Diagnosis and therapy of sepsis]. Clin Res Cardiol (2006) 0.87
The 2010 Guidelines on Neonatal Resuscitation (AHA, ERC, ILCOR): similarities and differences--what progress has been made since 2005? Klin Padiatr (2011) 0.87
Low-dose chemotherapy with vinblastine and methotrexate in childhood desmoid tumors. J Clin Oncol (1999) 0.87
Interaction of attention and graphomotor functions in children with attention deficit hyperactivity disorder. J Neural Transm Suppl (2007) 0.87
Subcellular proteomics reveals neuromelanin granules to be a lysosome-related organelle. J Neural Transm (Vienna) (2006) 0.87
Inhaled nitric oxide does not change transpulmonary angiotensin II formation in patients with acute respiratory distress syndrome. Chest (1997) 0.86
Leukocyte and endothelial activation in a laboratory model of extracorporeal membrane oxygenation (ECMO). Pediatr Res (2000) 0.86
Anti-melanin antibodies are increased in sera in Parkinson's disease. Exp Neurol (2009) 0.86
Behavioural and expressional phenotyping of nitric oxide synthase-I knockdown animals. J Neural Transm Suppl (2007) 0.86
[Diagnosis and therapy of sepsis: guidelines of the German Sepsis Society Inc. and the German Interdisciplinary Society for Intensive and Emergency Medicine]. Anaesthesist (2006) 0.86
Regional and age-dependent expression of the nitric oxide receptor, soluble guanylyl cyclase, in the human brain. Brain Res (2001) 0.85
One peptide, two topologies: structure and interconversion dynamics of human uroguanylin isomers. J Pept Res (1998) 0.85
Altered redox state of platelet coenzyme Q10 in Parkinson's disease. J Neural Transm (Vienna) (2000) 0.85
[Polyomavirus infections in exotic birds in Switzerland]. Schweiz Arch Tierheilkd (1999) 0.85
Endothelium and regulation of coagulation. Diabetes Care (1991) 0.85
Effects of secretin on extracellular amino acid concentrations in rat hippocampus. J Neural Transm (Vienna) (2004) 0.85
[Therapy of ARDS. 2. New management methods--first clinical experiences]. Anaesthesist (1994) 0.85